HemoShear Therapeutics develops new treatments for patients with rare metabolic disorders.

Biotechnology

Health Care

HemoShear Therapeutics

HemoShear Therapeutics' headquarters in Charlottesville, VA, United States

Brian Wamhoff

Teri Edwards

Mark Hayes

Ryan Feaver

Mike Simmers

Paul Sartori

Jeffrey Qureshi

Aric Holsinger

Michael Innes

Patrick Horn

Kathleen M. Metters

Gregory Enns

John Tilton

Moeen Al-Sayed

John E. Reardon

Arun Sanyal

John L. Brooks III

H. Thomas Watkins III

Robert J. Gould

Gerald Cox

Mattias Baumgartner

Nicola Longo

Kimberly Chapman

Tom Roper

Jerry Vockley

The Advisory and Governance team at HemoShear Therapeutics provides strategic guidance and oversight to ensure the company meets its objectives in developing new treatments for rare metabolic disorders. Comprised of board members and advisors, the team leverages their expertise to guide decision-making, ensure regulatory compliance, and uphold corporate governance standards.

Advisory and Governance

The Leadership Team at HemoShear Therapeutics drives the strategic direction and operational oversight of the company as it develops innovative treatments for rare metabolic disorders. This diverse group, comprising executives from finance, legal, regulatory, clinical operations, and marketing, collaborates to ensure regulatory compliance, foster partnerships, and guide clinical trials, all while aligning resources to meet company goals and patient needs.

Leadership Team

The Research and Development team at HemoShear Therapeutics focuses on discovering and developing new treatments for rare metabolic disorders. Leveraging expertise in discovery biology, exploratory biology, and computational biology, they work on identifying therapeutic targets, developing and testing new drug candidates, and advancing promising treatments through preclinical stages.

Research and Development

The Clinical Operations team at HemoShear Therapeutics orchestrates and oversees the execution of clinical trials for new treatments targeting rare metabolic disorders. This includes coordinating trial logistics, ensuring regulatory compliance, and facilitating communication across stakeholders to advance clinical programs efficiently.

Clinical Operations

HemoShear Therapeutics

Org chart

Board & advisors

Teams

Advisory and Governance

Leadership Team

Research and Development

Clinical Operations

Offices

HemoShear Therapeutics

Org chart

Board & advisors

Teams

Advisory and Governance

Leadership Team

Research and Development

Clinical Operations

Offices

Related companies